Showing 7431-7440 of 8649 results for "".
- Heru Releases re:Vive 2.0: A Single Wearable Platform with 6 Vision Diagnostic Modalities that Support 5 CPT Codeshttps://modernod.com/news/heru-releases-revive-20-a-single-wearable-platform-with-6-vision-diagnostic-modalities-that-support-5-cpt-codes/2480396/Heru announced it is expanding the capabilities of re:Vive by Heru, the company’s wearable gamified diagnostic solution, to include three new testing modalities: Color Vision CPT 92283, Contrast Sensitivity, and Dark Adaptation CPT 92284. “Since the inception of Heru, our go
- IACTA Pharmaceuticals Receives U.S. Department of Defense Funding of $1 Million to Conduct Preclinical Studies of IC 800 to Treat Pain Relief for Eye Injuryhttps://modernod.com/news/iacta-pharmaceuticals-receives-us-department-of-defense-funding-of-1-million-to-conduct-preclinical-studies-of-ic-800-to-treat-pain-relief-for-eye-injury/2480382/IACTA Pharmaceuticals announced that the U.S. Army Medical Research Acquisition Activity (USAMRAA), a division of the Department of Defense, has granted a $1 million award to the company to fund preclinical studies of IC 800, a novel therapy for the topical treatment of ocular pain utilizing
- Tilak Healthcare Raises €7m to Deploy Its Remote Vision Monitoring Platformhttps://modernod.com/news/tilak-healthcare-raises-eur7m-to-deploy-its-remote-vision-monitoring-platform/2480381/Tilak Healthcare, a developer of mobile games with medical modules to monitor patients with chronic ophthalmological conditions, has announced a €7 million fundraising round managed by Elaia, with the participation of Swen Capital Partners, Matmut Innovation, and co-founder
- iCare USA to Commercialize Oculo Software Solution Platform that Connects Doctors with Each Other and Their Patientshttps://modernod.com/news/icare-usa-to-commercialize-oculo-software-solution-platform-that-connects-doctors-with-each-other-and-their-patients/2480379/iCare USA’s parent company, Revenio, has announced its acquisition of Ocu
- Horizon Therapeutics: Newly Published Data Continue to Support Long-Term Efficacy of Tepezza for Thyroid Eye Disease (TED)https://modernod.com/news/horizon-therapeutics-newly-published-data-continue-to-support-long-term-efficacy-of-tepezza-for-thyroid-eye-disease-ted/2480371/Horizon Therapeutics announced additional data supporting the long-term efficacy of Tepezza for the treatment of TED. Data were published in
- New Essilor Vision Care Center Hosts First Virtual Global Varilux Summit Focused on Presbyopiahttps://modernod.com/news/new-essilor-vision-care-center-hosts-first-virtual-global-varilux-summit-focused-on-presbyopia/2480370/Essilor announced the creation of a digital event platform, the Essilor
- New 4-Year Data Show Genentech’s Enspryng Significantly Reduces Debilitating Relapses in People with NMOSDhttps://modernod.com/news/new-4-year-data-show-genentechs-enspryng-significantly-reduces-debilitating-relapses-in-people-with-neuromyelitis-optica-spectrum-disorder/2480350/Genentech announced new longer-term efficacy and safety data for Enspryng (satralizumab-mwge). The data show Enspryng has a favorable benefit-risk profile and is effective in reducing relapses over 4 years of treatment in people with anti-aquaporin-4 antibody (AQP4-IgG) seropositive NMOSD, a
- TissueTech Grows Salesforce to Support Footprint Expansionhttps://modernod.com/news/tissuetech-grows-salesforce-to-support-footprint-expansion/2480345/TissueTech, which applies cryopreserved human birth tissue allografts to treat ocular surface disease and disorders, chronic wounds,
- Market Scope: Factors Driving Retinal Pharma Pipelines are Injection Interval, Safety, and Pricehttps://modernod.com/news/market-scope-factors-driving-retinal-pharma-pipelines-are-injection-interval-safety-and-price/2480338/Longer injection intervals without gene therapy might be the theme for retinal pharmaceuticals in 2021, thanks to subsidiaries of the Roche Group filing marketing ap
- iCare USA Receives FDA 510(k) Clearance for Eidon Ultra-Widefield Lens Modulehttps://modernod.com/news/icare-usa-presents-ultra-widefield-imaging-for-the-eidon-diagnostics-platform/2480330/iCare USA has received FDA 510 (k) clearance for the Eidon Ultra-Widefield Lens module.&